Covestor’s Oruka Therapeutics ORKA Stock Holding History

Covestor’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	11 +7	+175%	+$466	﹤0.01%	2413
2026 Q1	$0	Buy	+4	New	+$139	﹤0.01%	2868

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Covestor's ORKA Position: Q2 2026 in Review

Covestor increased its Oruka Therapeutics (ORKA) stake by 175% in Q2 2026, buying an estimated $466 and bringing the position to 11 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Covestor first reported a position in ORKA in Q1 2026 and has held it in 2 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Covestor held 11 shares of Oruka Therapeutics worth $1K as of Q2 2026.
Covestor bought 7 Oruka Therapeutics shares in Q2 2026, an estimated $466.
Oruka Therapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2413 holding.
Covestor first reported a position in Oruka Therapeutics in Q1 2026 and has held it in 2 quarters since.
255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.